VR relaxation

Virtual Reality as a Relaxation Therapy in Clinical Psychiatry - VR relaxation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON58406

Enrollment

Registered

2025-06-20

Start date

2026-02-01

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression, psychosis, anxiety disorders depressie, psychose, angststoornissen

Interventions

The investigational treatment for this study consists of the Pico/Oculus VR headset and controller, paired with the VRelax app, designed to promote relaxation and reduce stress. This medical Virtual R

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Admitted to the psychiatric ward of the Erasmus MC Rotterdam during enrollment18 years of age or olderCapacity to provide informed consent regarding participation

Exclusion criteria

Exclusion criteria: No mastery over the Dutch language

Design outcomes

Primary

Measure	Time frame
The primary outcome is the immediate effect on level of momentary negative and positive affective states, measured with visual analog scales (VAS; range: 0-100). The VAS items are scored immediately before and after each session. Eight ecological momentary assessment items are selected that have been used in previous studies and have been related to psychological stress. The following items are scored for negative affective states: I feel distressed; anxious; down; nervous and the following for positive affective states: I feel relaxed; calm; cheerful; content.	—

Measure

Time frame

The primary outcome is the immediate effect on level of momentary negative and positive affective states, measured with visual analog scales (VAS; range: 0-100). The VAS items are scored immediately before and after each session. Eight ecological momentary assessment items are selected that have been used in previous studies and have been related to psychological stress. The following items are scored for negative affective states: I feel distressed; anxious; down; nervous and the following for positive affective states: I feel relaxed; calm; cheerful; content.

—

Secondary

Measure	Time frame
After each VR session, patients will complete a questionnaire to assess short-term changes in psychiatric symptoms and levels of stress. For this endpoint we utilize a modified, Dutch, 53-item version of the Brief Symptom Inventory (BSI).In order to further monitor possible changes in psychiatric symptoms, a treating psychiatrist will conduct the Brief Psychiatric Rating Scale (BPRS) within a week of each VR session. This scale gives insight in the mental wellbeing and psychiatric symptoms, as observed by the clinician.Other Measures Demographic and clinical information will be obtained from participants: age, sex, marital status, level of education, work situation, DSM-5 classification, illness duration, and psychotropic medication use. During VRelax sessions, how long participants spent in each environment is automatically recorded in log files. Cybersickness will be assessed to monitor adverse effects with a self-report Simulator Sickness Questionnaire (SSQ) before and after the VRelax intervention.	—

Measure

Time frame

After each VR session, patients will complete a questionnaire to assess short-term changes in psychiatric symptoms and levels of stress. For this endpoint we utilize a modified, Dutch, 53-item version of the Brief Symptom Inventory (BSI).In order to further monitor possible changes in psychiatric symptoms, a treating psychiatrist will conduct the Brief Psychiatric Rating Scale (BPRS) within a week of each VR session. This scale gives insight in the mental wellbeing and psychiatric symptoms, as observed by the clinician.Other Measures Demographic and clinical information will be obtained from participants: age, sex, marital status, level of education, work situation, DSM-5 classification, illness duration, and psychotropic medication use. During VRelax sessions, how long participants spent in each environment is automatically recorded in log files. Cybersickness will be assessed to monitor adverse effects with a self-report Simulator Sickness Questionnaire (SSQ) before and after the VRelax intervention. 

—

Countries

Netherlands

Contacts

Public ContactN.H. Grootendorst

Erasmus MC, Universitair Medisch Centrum Rotterdam

n.grootendorst@erasmusmc.nl0650008256

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026